Pharmaceutical cold chain management services ensure that temperature sensitive medicines and vaccines reach you safely. Without proper management, biologics and vaccines can lose potency—the World Health Organization estimates that up to half of vaccines are wasted globally due to inadequate temperature control. Zell- und Gentherapien sind noch anspruchsvoller; they often require ultra low temperatures below –80 °C to remain viable. As personalised medicines, biologics and mRNA vaccines become mainstream, the need for reliable cold chain services grows. This article demystifies the components, Vorschriften, technologies and trends shaping pharmaceutical cold chain management in 2025 and offers practical guidance tailored to your needs.
Why robust cold chain management services are essential – includes vaccine waste statistics and risks for cell and gene therapies
Key components of pharmaceutical cold chains – covers packaging, Transport, monitoring and skilled personnel
How regulations and standards affect your operations – summarises GDP, cGMP, TCR and WHO guidelines and offers compliance tips
Technologies reshaping cold chain logistics in 2025 – explores automation, IoT, Blockchain, AI and sustainable practices
Market insights and emerging trends – provides fresh data on market size, growth drivers and regional variations
Praxistipps und FAQs – offers actionable advice and answers to common questions
Why Are Pharmaceutical Cold Chain Management Services Critical?
Cold chains protect patient safety and business value. Temperature excursions can degrade biologics, vaccines and cell therapies, leading to financial waste and compromised efficacy. Recent research shows that up to 20 % of temperature sensitive healthcare products are damaged during distribution. With the cell and gene therapy market projected to exceed USD 81 Milliarden von 2029, any failure can jeopardise life saving treatments. Gute Vertriebspraxis (BIP) and related regulations mandate validated systems to maintain temperature integrity and traceability. Bei Nichtbeachtung kann es zu Produktrückrufen kommen, regulatory penalties and loss of trust.
Temperature Sensitivity of Modern Medicines
Different therapies have distinct temperature requirements. Understanding these ranges helps you select the right packaging, transport and monitoring solutions. The table below summarises key categories:
| Temperaturbereich | Examples of Products | Praktische Bedeutung für Sie |
| Controlled ambient (15 - - 25 °C) | Tablets, some antibiotics | Use insulated packaging to prevent spikes; logistics are simpler but still require traceability. |
| Gekühlt (2 - - 8 °C) | Impfungen, Insulin, GLP-1-Medikamente | Stay within a narrow band; delays or poor packaging can render products ineffective. |
| Gefroren (–20 °C bis 0 °C) | Certain biologics, Blutprodukte | Requires robust insulation and phase change materials; monitoring is crucial to avoid thawing. |
| Deep frozen / kryogen (< –80 °C) | Zell- und Gentherapien, mRNA-Impfstoffe | Needs specialised freezers and dry ice or liquid nitrogen; even short excursions can destroy potency. |
Praktische Implikationen: If your product falls into the refrigerated or frozen categories, ensure your logistics provider uses validated packaging with phase change materials (PCMs) and real time monitoring. For cryogenic therapies, portable ultra low freezers and dry ice replenishment should be standard. Always assess each product’s stability profile and define acceptable temperature ranges and excursion durations.
Regulatory Frameworks: BIP, cGMP, TCR and WHO Guidelines
Regulators enforce strict rules to safeguard product quality. Gute Verteilungspraktiken (BIP) and IATA Temperature Control Regulations (TCR) require Time and Temperature Sensitive labels on air cargo and mandate acceptance checklists. The FDA’s current Good Manufacturing Practice (cGMP) regulations stipulate that drugs must be stored under appropriate conditions of temperature, humidity and light. Die Weltgesundheitsorganisation (WER) Good Distribution Practices provide guidance on maintaining acceptable temperatures, pest control and calibrated monitoring equipment. The following table summarises key frameworks:
| Rahmen | Geographic scope | Zweck | Was es für Sie bedeutet |
| EU-BIP-Richtlinien | Europa | Define standards for wholesale distribution of medicines; ensure correct storage, stock turnover and traceability | Store products within specified temperatures, document stock movements and perform quality audits. |
| HIER IST TCR | International air freight | Require Time and Temperature Sensitive labels on cargo and training for ground handlers | Label cargo with temperature range, complete checklists and train staff to handle temperature sensitive consignments. |
| FDA cGMP (21 CFR -Teil 211) | Vereinigte Staaten | Mandate proper storage conditions, stability testing and equipment calibration | Überwachen Sie die Temperatur, humidity and light; perform stability testing and keep calibration records. |
| WHO GDP | Global | Provide guidance on maintaining acceptable temperatures and mapping storage areas | Calibrate thermometers, conduct temperature mapping and store monitoring data for at least shelf life plus one year. |
| USP <1079> Good Storage and Shipping | Vereinigte Staaten | Recommend medical grade refrigeration, stability testing and digital data loggers | Use medical grade fridges with fan forced air circulation and monitor temperature daily with digital data loggers. |
Tipps zur Compliance:
Create a regulatory matrix that lists each product’s destination markets and corresponding regulations; this prevents oversight when exporting to multiple regions.
Standardise SOPs: develop procedures that satisfy the strictest requirements across regulations to reduce complexity.
Centralise documentation: maintain a unified quality management system where calibration certificates, temperature logs and training records are stored.
Engage certified third party logistics providers: ensure your partners understand GDP, TCR and cGMP requirements and have appropriate equipment.
Bleib informiert: subscribe to updates from agencies like EMA, FDA and IATA to remain compliant.
Key Components of Pharmaceutical Cold Chain Management Services
Maintaining drug potency demands a holistic approach built on four pillars: Verpackung, Transport, kontinuierliche Überwachung Und skilled personnel. Each component works together to prevent temperature excursions, contamination and delays.
Verpackungslösungen: From Phase Change Materials to Eco Friendly Innovations
Packaging is your first line of defence. Modern solutions use insulation, phase change materials and smart cooling systems to maintain required temperatures. The following table summarises common options and their benefits:
| Verpackungslösung | Beschreibung | Praktischer Nutzen |
| Phasenwechselmaterialien (PCMs) | Materials that absorb or release latent heat at target temperatures | Stabilise temperature during transit; reduce dependence on external power. |
| Vakuumisolierte Paneele (VIPs) | High performance insulation panels with minimal thermal conductivity | Extend shipment duration without dry ice; Ideal für lange Strecken. |
| Cryogenic Freezers | Portable units capable of maintaining –80 °C to –150 °C storage | Support cell and gene therapy shipments and remote clinical trials. |
| Reusable gel or water based ice packs | Maintain 2–8 °C or below; water based packs emit 39 % less CO₂ during production | Reduce carbon emissions and offer cost savings (5.7 tonnes of CO₂ saved per million packs). |
| Eco friendly insulation materials | Paper based liners, fibre composites and recyclable plastics | Reduce single use plastic waste and align with circular economy goals. |
Praktische Tipps: Use validated packaging that matches your product’s temperature range. For long haul shipments, consider VIPs combined with PCMs to reduce dry ice consumption. When sustainability matters, choose eco friendly materials and water based ice packs to lower your carbon footprint.
Transportation and Handling: Keeping Products Safe on the Move
Transportation is more than moving goods; it’s about maintaining conditions from door to door. Passive cooling solutions (Isolierte Behälter) are complemented by active systems—refrigerated trucks, air freight containers and temperature controlled warehouses. In 2024, transportation services accounted for 46.3 % of the healthcare cold chain logistics market and air freight held 41 % Marktanteil. Befolgen Sie diese Best Practices:
Routenplanung: use predictive analytics and AI to avoid traffic, customs delays and extreme weather.
GPS enabled shippers: real time location and temperature data allow immediate intervention during deviations.
Contingency stock: keep backup coolant, dry ice or portable freezers for unexpected delays.
Monitor hand offs: ensure clear responsibility at transfer points between carriers, warehouses and clinics.
Continuous Monitoring and Skilled Personnel
Monitoring is the nervous system of the cold chain. IoT -Sensoren, data loggers and wireless communication provide end to end visibility. These devices collect temperature, humidity and location data every few minutes, sending alerts via SMS or app when thresholds are breached. Blockchain creates a tamper proof ledger of temperature and chain of custody data, improving transparency and compliance. KI und Predictive Analytics optimise routes and anticipate equipment failures by analysing real time and historical data.
Skilled personnel remain essential. Lokführer, warehouse staff and quality teams on GDP requirements, loading practices, monitoring equipment and corrective actions. Regular drills and refresher courses help prevent human error—the leading cause of cold chain failures. Establish SOPs for responding to temperature excursions, including quarantine, documentation and root cause analysis.
Technologies Shaping Cold Chain Management in 2025
Pharmaceutical cold chains are being transformed by technologies that improve compliance, Effizienz und Nachhaltigkeit. The table below summarises the main innovations and their benefits:
| Technologie | Beispiel Verwendung | Vorteile | Bedeutung für Sie |
| Automatisierte Lagerung & retrieval systems (AS/RS) | Robots and cranes move pallets in cold warehouses | Reduce labour costs and errors; laufen 24/7 | Faster order fulfilment and consistent temperature control |
| IoT -Sensoren & Echtzeitverfolgung | Connected devices monitor temperature, Luftfeuchtigkeit und Standort | Detect issues quickly; provide data for audits; improve customer trust | Less spoilage and easier compliance |
| Künstliche Intelligenz & prädiktive Analytik | Algorithms forecast demand, predict equipment failures and optimise delivery routes | Prevent breakdowns; cut fuel use; anticipate demand spikes | Reduced delays, lower costs and improved service reliability |
| Blockchain | Tamper proof digital ledger recording each shipment event | End to end traceability; faster customs clearance; fraud reduction | Builds trust with regulators and customers |
| Robotik & drones | Autonomous vehicles and drones handle packages and last mile delivery | Expand last mile reach; operate efficiently in remote areas | Faster deliveries and reduced labour shortages |
Automatisierung und Robotik
Nur etwa 20 % of warehouses are automated, leaving ample room for efficiency gains. Automatisierte Lager- und Bereitstellungssysteme (AS/RS) and robotic handlers operate continuously, Verbesserung des Durchsatzes und Reduzierung menschlicher Fehler. When implementing robotics, start with high volume areas where pick and place activities are repetitive. Automation not only lowers costs but also maintains consistent temperature zones, preventing “hot spots” in high density warehouses.
IoT-fähige Überwachung
IoT devices—sensors, smart tapes and data loggers—collect temperature, humidity and location data every few minutes. Integration with GPS ensures precise tracking and enables proactive intervention. Combining IoT data with predictive analytics identifies patterns that may lead to excursions, such as equipment malfunction or customs delays. Choose devices with long battery life and regulatory compliance, and integrate their data into cloud dashboards for real time analysis.
Blockchain for End to End Traceability
Blockchain records transactions in an immutable ledger. In der kalten Kette, it creates a shared, tamper proof history of temperature readings and chain of custody events. This technology is especially useful for vaccines and high value biologics where data integrity is paramount. Implement blockchain when multiple partners (manufacturers, Träger, Kliniken) need shared visibility and trust. Integrate blockchain data with existing quality systems to simplify audits and accelerate customs clearance.
Künstliche Intelligenz und Predictive Analytics
AI algorithms optimise routes, anticipate equipment failures and forecast demand. AI powered route optimisation leverages traffic and weather analysis to shorten transit times. Predictive analytics identify patterns that may lead to temperature excursions before they occur, allowing corrective actions such as rerouting shipments or replacing faulty equipment. Use AI not only for routing but also for inventory management and demand forecasting to reduce waste and stock outs.
Sustainable Practices and Packaging
Cold chain logistics consume significant energy and contribute about 2 % der weltweiten CO₂-Emissionen. Regulators and consumers expect greener operations. Sustainable packaging solutions—such as recyclable insulated containers, biodegradable wraps and reusable cold packs—reduce waste and carbon footprint. Water based ice packs emit 39 % less CO₂ compared with gel packs and save 5.7 tonnes of CO₂ per million packs. Energy efficient refrigeration upgrades and solar powered cold storage units lower operating costs; solar rates range from 3.2–15.5 ¢/kWh, below the average utility rate of 13.10 ¢/kWh. Incorporate hybrid energy sources and renewable refrigerants to meet environmental goals and reduce expenses.
Smart Packaging and Real Time Data
Smart packaging integrates sensors and communication modules directly into containers, transmitting real time temperature data to logistics teams. This approach reduces risk of lost shipments and supports analytics by aggregating data across shipments. Start with pilot projects for high value products and ensure your IT infrastructure can handle the data volume.
Current Trends and Market Insights for 2025
The pharmaceutical cold chain market is expanding rapidly. The cold chain pharma market grew from USD 8.85 Milliarden in 2024 in USD 10.04 Milliarden in 2025 und wird voraussichtlich erreicht werden USD 18.2 Milliarden von 2030 mit a 12.75 % CAGR. Healthcare cold chain logistics overall reached USD 62.5 Milliarden in 2025 and is projected to hit USD 95.1 Milliarden von 2030, darstellen a 9.5 % CAGR. Transportdienstleistungen entfallen 46.3 % of the market and air freight holds 41 % Aktie.
Market Growth Drivers
Mehrere Faktoren treiben dieses Wachstum voran:
Rise of biologics, Zell- und Gentherapien: advanced therapeutics require cryogenic logistics and precise temperature control. These therapies are expanding at an 18.9 % CAGR.
Global vaccination campaigns and pandemic stockpiles: mass immunisation efforts continue to demand robust cold chain distribution.
Stricter regulatory enforcement: regulators are tightening GDP and Good Manufacturing Practice requirements, increasing inspection frequency and traceability expectations.
Infrastructure investments: expansion of temperature controlled warehouses and logistics networks improves coverage and reliability.
Decentralised clinical trials and direct to patient deliveries: moving trials outside traditional sites boosts last mile cold chain demand.
Aufkommende Trends
The following trends will shape cold chain management through 2025:
Ultra cold and cryogenic logistics: portable freezers capable of maintaining –80 °C to –150 °C are becoming standard for gene therapies.
End to end visibility and real time data: integration of IoT, blockchain and AI delivers complete traceability and rapid response to deviations.
Automatisierung und Robotik: labour shortages accelerate adoption of robotic systems, improving efficiency and reducing errors.
Nachhaltigkeit und Kreislaufwirtschaft: umweltfreundliche Verpackung, solar powered storage and reduced emissions are priorities. Water based refrigerants and recyclable liners align with regulations and consumer expectations.
Decentralised manufacturing and localised supply chains: to mitigate global disruptions, pharmaceutical companies invest in local production facilities and micro fulfilment centres.
Market Insights and Regional Variations
Region specific data reveal where opportunities and challenges lie:
| Region/Sector | 2025 Wert | Wachstumstreiber | Implikationen |
| Global cold chain logistics | USD 436.3 Milliarde | Rising demand for perishable foods and biologics; e commerce and direct to consumer models | Companies must expand capacity and adopt technology to handle volume. |
| Asien-Pazifik | Highest CAGR (~14.3 %) | Bevölkerungswachstum, urbanisation and new health regulations | Opportunity for investment in modern warehouses and refrigerated fleets. |
| Nordamerika (food cold chain) | USD 86.67 Milliarden von 2025 | Growth in meal kits, plant based products and organic foods | Demand for last mile cold storage and sustainable packaging. |
| Pharmaceutical cold chain | CAGR 4.71 % (2024 2029) and projected volume USD 1,454 Milliarden von 2029 | Gene and cell therapies, Impfstoffe und Biologika | Need for ultra cold storage, cryogenic freezers and traceability. |
| Kühlkettenverpackung | USD 30.88 Milliarden in 2025 wächst auf USD 64.49 Milliarden von 2032 | Demand for temperature controlled shipping and eco friendly packaging | Opportunities for reusable pallet shippers, VIPs and biodegradable wraps. |
Navigating Regulations and Compliance in the Pharmaceutical Cold Chain
Why regulations matter: GDP and TCR guidelines protect patients and preserve drug potency by ensuring medicines are stored and transported under correct conditions. Regulations unify quality standards across borders, preventing counterfeit products and facilitating global supply chains. The Drug Supply Chain Security Act (DSCSA) and the EU’s Falsified Medicines Directive demand serialization and tracking to prevent counterfeit medicines. The FDA’s 21 CFR 211.142 mandates that drug products be stored under appropriate conditions of temperature, humidity and light. Zusammen, these rules require robust processes, continuous monitoring and corrective actions.
Understanding GDP, TCR and cGMP Requirements
| Erfordernis | Quelle | Einzelheiten | Warum es dir wichtig ist |
| Storage conditions | EU-BIP; FDA 21 CFR 211.142 | Maintain appropriate temperature, humidity and light to preserve product quality | You must record storage conditions and adjust equipment to stay within specified ranges. |
| Temperature mapping and calibration | WHO-Richtlinien | Calibrate monitoring devices and map storage areas to identify hot or cold spots | Mapping ensures sensors are placed where fluctuations are likely, preventing unnoticed excursions. |
| Labelling and documentation | HIER IST TCR | Use Time and Temperature Sensitive labels on air cargo and complete acceptance checklists | Proper labelling ensures handlers understand the required temperature range; checklists verify compliance before loading. |
| Traceability and serialization | DSCSA; EU Falsified Medicines Directive | Implement serialization and tracking systems to identify individual packages | Traceability prevents counterfeit products and enables rapid recalls in case of quality issues. |
| Equipment qualification and monitoring | USP <1079>; CDC Toolkit | Use medical grade equipment, perform stability and recovery testing and monitor temperature continuously with digital data loggers | Qualified equipment maintains uniform temperatures; continuous monitoring detects excursions early and preserves product potency. |
Implementing Best Practices: Practical Tips for Your Cold Chain Program
Investing in proper infrastructure and procedures reduces risk and supports compliance. Here are actionable tips based on industry evidence:
Assess product stability: work with quality teams to define acceptable temperature ranges, excursion durations and contingency plans.
Investieren Sie in Ausbildung: human error is a leading cause of excursions; regularly train staff on loading practices, monitoring equipment and corrective actions.
Use validated packaging: adopt phase change materials and vacuum insulated panels to maintain stable temperatures during delays.
Create emergency SOPs: develop standard operating procedures for responding to deviations, including quarantine, documentation and root cause analysis.
Perform temperature mapping: calibrate sensors and map storage areas to identify hot spots and ensure sensors are placed where fluctuations occur.
Implementieren Sie eine digitale Überwachung: equip shipments with IoT sensors and integrate data into dashboards for real time analysis.
Planen Sie Nachhaltigkeit: switch to eco friendly packaging, water based refrigerants and solar powered cold storage to reduce carbon footprint and energy costs.
Form strategic partnerships: collaborate with local technology providers, packaging firms and third party logistics partners to expand capacity and share expertise.
Tatsächlicher Fall: During the Pfizer–BioNTech COVID 19 vaccine rollout, ultra low temperature requirements (–70 °C) posed significant logistics challenges. The company used GPS enabled thermal shippers, routine dry ice replenishment and continuous digital monitoring to ensure safe delivery. This example highlights the importance of proactive monitoring and validated packaging for new therapies.
2025 Neueste Entwicklungen und Trends
Cold chain logistics are evolving quickly, with innovations and market dynamics reshaping operations across sectors. This section highlights notable developments.
Automatisierung, IoT and AI: The Engine of 2025 Cold Chain Updates
The convergence of automation, IoT and AI drives productivity and transparency. Wie bereits erwähnt, automatisierte Lager- und Bereitstellungssysteme, IoT sensors and predictive analytics work together to maintain temperature and optimise routes. IoT devices provide real time visibility into temperature, Luftfeuchtigkeit und Standort, allowing you to detect issues before spoilage occurs. AI analyses this data to optimise routes, forecast demand and perform predictive maintenance. Kombiniert, these technologies reduce waste, improve compliance and deliver faster, more reliable service.
Market Dynamics and Diversification
The cold chain logistics market is expanding from a niche service to critical infrastructure. The global market is valued at USD 436.3 Milliarden in 2025 with a forecast CAGR of 13.46 % durch 2034. Asien–Pazifik leads growth (um 14.3 % CAGR) due to population expansion and new health regulations, während Nordamerika drives demand for last mile cold storage and sustainable packaging, geschätzt bei USD 86.67 Milliarde. Pharmaceutical cold chain services, fuelled by gene and cell therapies, require ultra cold storage and advanced tracking. The cold chain packaging market will grow from USD 30.88 Milliarden in 2025 Zu USD 64.49 Milliarden von 2032, reflecting increased demand for vacuum insulated panels, reusable pallet shippers and biodegradable wraps.
Nachhaltigkeit und Regulierung
Nachhaltigkeit ist nicht mehr optional. Cold chain logistics produces roughly 2 % der weltweiten CO₂-Emissionen. Solar powered cold storage units reduce operating costs—commercial solar rates range from 3.2–15.5 ¢/kWh gegenüber 13.10 ¢/kWh average utility rates. Moving frozen storage from –18 °C to –15 °C reduces energy consumption without compromising safety. Nachhaltige Verpackung, such as recyclable containers and biodegradable wraps, lowers environmental impact and meets emerging regulations. Policies like the Gulf region’s Net Zero 2050 strategy and the adoption of BRC and SQF standards drive investment in energy efficient infrastructure and advanced traceability.
Blockchain, Solar and Cryogenic Innovations
Innovationen umfassen blockchain enabled traceability, Solarbetriebener Kühlraum, IoT -Sensoren, KI-gestützte Routenoptimierung Und tragbare kryogene Gefriergeräte. Blockchain pilots have cut customs clearance times by recording shipment events in an immutable ledger. Solar powered cold storage reduces costs and ensures product integrity in remote regions. IoT enabled sensors send real time alerts for temperature deviations, while AI uses traffic and weather data to plan routes and reduce fuel consumption. Portable cryogenic freezers maintain –80 °C to –150 °C with real time tracking, supporting transport of biologics and gene therapies.
Regional Trends and Strategic Partnerships
Different regions face unique challenges and opportunities. Im Nahen Osten, extreme heat and complex cross border trade drive investment in IoT, AI and blockchain to provide real time visibility and predictive intelligence. Solar powered storage and compostable packaging align with regional sustainability goals. Asia Pacific focuses on expanding cold storage capacity and adopting advanced packaging technologies. North America emphasises last mile delivery and direct to consumer models, investing in robotics, drones and data analytics. Europe’s strict regulations push adoption of advanced temperature control and sustainable materials.
Strategic partnerships between food producers, packaging suppliers and technology providers improve resilience and product development. Von 2025, rund 74 % der Logistikdaten werden standardisiert, Ermöglicht eine nahtlose Integration über Lieferketten hinweg.
Häufig gestellte Fragen
Q1: Why is cold chain important for vaccines and biologics?
Vaccines and biologics are sensitive to temperature changes; even small excursions can render them ineffective. Up to half of vaccines may be wasted globally each year due to inadequate temperature control. A validated cold chain preserves efficacy and protects patient safety.
Q2: How do IoT sensors enhance cold chain monitoring?
IoT sensors collect temperature and location data in real time, sending alerts when conditions deviate from set ranges. They enable proactive intervention, reduce waste and provide auditable records for regulators.
Q3: Was sind Phasenwechselmaterialien??
Phasenwechselmaterialien (PCMs) absorb or release heat at a specific temperature, stabilising the internal environment of a package. They help maintain temperature without continuous power and reduce dry ice consumption.
Q4: How does blockchain benefit the pharmaceutical cold chain?
Blockchain creates a tamper proof ledger of temperature data, chain of custody events and regulatory documentation. It improves transparency, security and compliance, especially when multiple stakeholders are involved.
Q5: Can sustainable packaging meet strict temperature requirements?
Ja. Innovations such as water based refrigerants, biodegradable liners and vacuum insulated panels offer high thermal performance while reducing carbon emissions. Companies adopting these materials align with regulations and consumer demand for eco friendly solutions.
Zusammenfassung & Empfehlungen
Key Takeaways:
Prioritise product integrity and compliance: bis zu 50 % of vaccines are wasted due to poor temperature control. Invest in validated packaging, real time monitoring and staff training to reduce risk.
Vorschriften verstehen: adhere to GDP, cGMP and TCR requirements and maintain proper documentation. Create a regulatory matrix to navigate overlapping standards.
Nutzen Sie Technologie: Automatisierung, IoT -Sensoren, blockchain and AI optimise routes, ensure traceability and reduce operational costs. Start with small pilots, dann skalieren.
Setzen Sie auf Nachhaltigkeit: umweltfreundliche Verpackung, water based refrigerants and solar powered storage cut emissions and energy costs.
Überwachen Sie Markttrends: anticipate growth in cell and gene therapies, decentralised clinical trials and regional market expansions. Align your strategy with emerging trends.
Aktionsplan:
Assess your current cold chain program: perform a gap analysis against regulatory requirements and industry best practices.
Implement continuous monitoring: adopt IoT sensors and integrate data into a central dashboard for real time visibility.
Pilotieren Sie neue Technologien: test automation, blockchain or smart packaging on a small scale to evaluate benefits before full deployment.
Train and empower staff: ensure personnel are equipped to use new tools and follow GDP compliant procedures.
Experten einbeziehen: consult specialised cold chain providers like Tempk to design customised solutions and stay ahead of industry trends.
Über Tempk
Tempk is a trusted partner in cold chain logistics, providing innovative packaging, temperature controlled transport solutions and comprehensive monitoring technologies. Our research and development centre focuses on sustainable materials and cutting edge sensors. We offer validated insulated boxes, Wiederverwendbare Eisbeutel, vacuum insulated panels and portable cryogenic freezers. We’ve helped clients reduce carbon emissions by 39 % with water based ice packs and save 5.7 tonnes of CO₂ per million packs. With certified facilities and experienced personnel, Tempk ensures regulatory compliance, product integrity and on time delivery across the globe.
Get started today: Contact us to discuss your unique cold chain requirements. Our experts will design a tailored solution to protect your products, meet regulations and achieve sustainability goals.
